Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

NCT00614978 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Brain Metastases
HER2 Positive

Interventions

DRUG: lapatinib and temozolomide

Sponsor

Jules Bordet Institute

Collaborators

[object Object]
[object Object]